Intraarticular Corticosteroid Therapy in Perthes Disease.

Stopped early · Not applicable

Conditions studied: Legg-Calve Perthes Disease

In brief

Legg-Calve-Perthes disease (LCP) represents the loss of blood flow to the head of the femur, resulting in significant hip pain and potential long term disability. This study represents a single center, randomized, prospective, controlled study comparing the treatment of LCP with an intraarticular corticosteroid (triamcinolone hexacetonide) injection with traditional nonoperative treatment.

Key facts

Study ID

NCT01026909

Run by

Seattle Children's Hospital

People needed

3

Starts

2009-03-01

Expected to finish

2014-01-01

Last updated by the study team

2016-01-29

Who can join

Age: 4 and older, up to 13. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age of 4 to 12 years
• diagnosed with Idiopathic osteonecrosis of the femoral head
• symptoms less than 12 months old.

You may not qualify if…

• Symptoms for more than 12 months
• Previous treatment other than anti-inflammatories, crutches or bed rest
• Subjects more than 8 years old or have a hand bone age greater than 6 years old and lateral pillar B or B/C disease.
• Bilateral hip disease
• Personal or family history of problems with general anesthesia
• Prior steroid treatment
• Previous diagnosis of:
• Asthma
• Identifiable rheumatologic condition
• Metabolic Diseases (including but not limited to Gaucher's disease or congenital hypothyroidism)
• Sickle cell disease
• Known pain syndrome
• Hip sepsis
• Prior malignancy (solid organ or bone marrow transplant)
• Blood Clotting disorder

Where it is running

• Seattle Children's Hospital — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.